MetaCap

Vistagen Therapeutics Statistics

NASDAQ: VTGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.1636-0.023 (-12.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Vistagen Therapeutics by the numbers

Vistagen Therapeutics has a market capitalization of $7.6 million based on 46.19M shares outstanding. With trailing EPS of $-1.36, Vistagen Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.7% below its 50-day average and 60.5% below its 200-day average.

Average daily trading volume is 10.30M shares, or about $1.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VTGN valuation vs. peer median

VTGN compared with the median of 8 peer companies
MetricVTGNPeer medianDifference
Market cap$7.56M$7.33M+3%
Avg. volume10.30M415.77K+2378%

Peer median across 8 companies: RKTO, PHIO, IMRN, CLRB, DARE, CVKD, ENSC, TCRT.

Valuation

Price / sales (latest FY)
5.95
EPS (TTM)
$-1.36

Price and trading

Previous close
0.1866
Open
0.185
Day range
0.1635 – 0.1915
52-week range
0.16 – 5.14
52-week change
-96.44%
Beta
—
Volume
908.86K

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
7.56M
Forward Pe
-0.13
Eps
-1.36
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.14
Week52 Low
0.16
Avg Volume
10.30M
Shares Outstanding
46.19M
Ma50
0.22
Ma200
0.41
Earnings Date
Nov 13, 2026
Pct From52w High
-96.82%
Pct From52w Low
2.25%

Related